Article Details
Retrieved on: 2022-06-07 05:21:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley reiterated an “overweight” rating on shares of AstraZeneca in a research note on Wednesday, May 11th. Jefferies Financial Group set a ...
Article found on: www.defenseworld.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here